Portage Biotech (PRTG) announced that on June 24, 2025, the Company received formal notice from The Nasdaq Stock Market that the Company has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRTG:
- Portage Biotech and Compedica Forge Strategic Alliance with Stock Exchange
- Portage Biotech, Compedica enter mutual subscription agreement
- Portage Biotech Appoints New Auditor Following Marcum Resignation
- Portage Biotech files $40M mixed securities shelf
- Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma